Cargando…

Management of Parkinson’s disease challenged by co-morbid drug abuse

INTRODUCTION: Parkinson’s disease (PD) is a neurologic degenerative condition with complex neuropsychiatric manifestations which can be challenging to manage and greatly impact quality of life and prognosis. OBJECTIVES: The description of this case aims to highlight the complex interaction between P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simas, J., Delgado, A., Guedes, R., Silveira, C., Soares, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566004/ http://dx.doi.org/10.1192/j.eurpsy.2022.1188

Ejemplares similares

30.1 IMMUNE PATHOGENESIS OF PSYCHOSIS: THE CHALLENGE OF CO-MORBIDITY
por: Upthegrove, Rachel, et al.
Publicado: (2018)

Challenges for Elder Abuse Prevention Law
por: Tsukada, Noriko, et al.
Publicado: (2020)

Illicit drug use and co-morbidities: a gender perspective
por: Torrens, M.
Publicado: (2023)

Adult attention-deficit/hyperactivity disorder and bipolar disorder: diagnostic and management challenges
por: Barbosa, M., et al.
Publicado: (2022)

Cancer morbidity in alcohol abusers.
por: Tønnesen, H., et al.
Publicado: (1994)

Co-morbidities of persons dying of Parkinson's disease
por: Lethbridge, Lynn, et al.
Publicado: (2013)

Psychiatric co-morbidity associated with pheniramine abuse and dependence
por: Pal, Hemraj, et al.
Publicado: (2005)

Challenges for Private LTC Service Providers for Preventing Elder Abuse
por: Ikeda, Naoki, et al.
Publicado: (2020)

Substance abuse co-morbidity in schizophrenia: An inpatient study of course and outcome
por: Aich, Tapas K., et al.
Publicado: (2005)

Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006
por: Nyhlén, Anna, et al.
Publicado: (2011)

The relationship between self-stigma and sociodemographic variables in people with substance abuse
por: Silveira, Pollyanna, et al.
Publicado: (2012)

Neuropsychiatric co-morbidities in non-demented Parkinson's disease
por: Rai, Nirendra Kumar, et al.
Publicado: (2015)

Psychiatric Morbidity of Cannabis Abuse
por: Sarkar, Jaydip, et al.
Publicado: (2003)

The challenge of neuropsychiatric manifestations in parkinson’s disease. A case report
por: Del Campo, A. Cerame, et al.
Publicado: (2021)

Psychosis in Parkinson’s Disease: a Case Report of Diagnosis and Management
por: Andrade, R. P. L., et al.
Publicado: (2023)

Prescription drug abuse in migrants from Middle Eastern and North African countries: a review
por: Portela, C., et al.
Publicado: (2023)

Challenges for Prevention of Elder Abuse in Japan: Viewpoints From Legal and Practice Settings
por: Thomas, Cynthia, et al.
Publicado: (2020)

“I have no disease and weed just relaxes me!”: The therapeutic challenge in young patients with psychosis and cannabis abuse
por: Mota, P.
Publicado: (2021)

Telemedicine in the Management of Parkinson’s Disease: Achievements, Challenges, and Future Perspectives
por: Cubo, Esther, et al.
Publicado: (2022)

Pharmacological Management of insomnia Associated with Parkinson’s Disease
por: Vasiliu, O.
Publicado: (2022)

42. METABOLISM AND CO-MORBIDITIES IN PSYCHOTIC DISORDERS
por: Oresic, Matej
Publicado: (2018)

Psychiatric co-morbidity and substance abuse after gastric bypass surgery
por: Svensson, Carl Johan, et al.
Publicado: (2023)

Precarious Data: Crack, Opioids, and Visualizing a Drug Abuse Epidemic
por: Welhausen, Candice
Publicado: (2019)

783. Infectious complications in IV abusers: a detailed review of hospitalized IV abusers
por: Gonzalez, Jaime, et al.
Publicado: (2019)

Psychological morbidity among female commercial sex workers with alcohol and drug abuse
por: Pandiyan, Kasthuri, et al.
Publicado: (2012)

Diagnostic Issues in Other Mental Disorders Co-Morbid With Intellectual Disability
por: Albuquerque, J. P.
Publicado: (2023)

Amphetamine Dependence and Co-Morbid Alcohol Abuse: Associations to Brain Cortical Thickness
por: Lawyer, Glenn, et al.
Publicado: (2010)

Corrigendum to: Psychiatric co-morbidity and substance abuse after gastric bypass surgery
Publicado: (2023)

Infuence of co-morbidity in the prognosis of politrauma in geriatric patients
por: Famà, F, et al.
Publicado: (2011)

Prisoners with Attention Deficit Hyperactivity Disorder: Co-morbidities & Service Pathways
por: Rawat, A., et al.
Publicado: (2022)

Molecular lipids in prediction of psychosis and the associated cardiometabolic co-morbidities
por: Oresic, M.
Publicado: (2021)

Multidisciplinary Healthcare Providers’ Perspectives on Managing Suspected Elder Abuse in the Healthcare Setting
por: Makaroun, Lena, et al.
Publicado: (2020)

Spousal abuse and psychological repercussions
por: Kolsi, S., et al.
Publicado: (2021)

Spousal abuse and its determinants
por: Kolsi, S., et al.
Publicado: (2021)

Clozapine use in drug induced psychosis in Parkinson´s disease: a case report and review of literature.
por: Sanz Giancola, A., et al.
Publicado: (2023)

Sexual harassment-abuse and psychotherapy: the strenght of therapeutic relathionship
por: Moutafi, C., et al.
Publicado: (2022)

Proposed Features for a Digital Nutrition Intervention for Managing Parkinson’s Disease
por: LoBuono, Dara, et al.
Publicado: (2020)

Comparing Elder and Child Abuse Prevention Approaches in Japan: Strategies for Reducing Elder Abuse
por: Katsumata, Asako, et al.
Publicado: (2020)

Poisoning with Drugs of Abuse: Identification and Management
por: Shukla, Lekhansh, et al.
Publicado: (2019)

977. The Prevalence and Burden of Non-AIDS Co-Morbidities in Women with or At-risk for HIV Infection in the United States
por: Collins, Lauren F, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vtu359q1diu71ahbr8ruh2hn1o